Recent advances in the management of diabetic distal symmetrical polyneuropathy
about
MR Micro-Neurography and a Segmentation Protocol Applied to Diabetic Neuropathy.Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy.Acute and subchronic in-vivo effects of Ferula hermonis L. and Sambucus nigra L. and their potential active isolates in a diabetic mouse model of neuropathic painImpact of educational interventions in reducing diabetic complications: a systematic review.Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label studyLarge-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes.HLA class II alleles and risk for peripheral neuropathy in type 2 diabetes patients.Risk factors for neuropathic pain in diabetes mellitus.The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy.Yang-warming method in the treatment of diabetic peripheral neuropathy: an updated systematic review and meta-analysis.Clinical efficacy of aconitum-containing traditional Chinese medicine for diabetic peripheral neuropathic pain.Effect of a polyherbal formulation cream on diabetic neuropathic pain among patients with type 2 diabetes - A pilot studyTransplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy.Relationships between presynaptic inhibition and static postural sway in subjects with and without diabetic neuropathy.Randomized Trial of the Effect of Mindfulness-Based Stress Reduction on Pain-Related Disability, Pain Intensity, Health-Related Quality of Life, and A1C in Patients With Painful Diabetic Peripheral Neuropathy.Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients.The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.Neuropathic Pain: Delving into the Oxidative Origin and the Possible Implication of Transient Receptor Potential Channels.Single Sensor Gait Analysis to Detect Diabetic Peripheral Neuropathy: A Proof of Principle Study.Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46).Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials.Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalinAlpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
P2860
Q33711789-F30903FE-8B01-4CD9-8880-ECF6A40E523FQ34085762-35D99C2E-B645-4CE6-85EA-6203789BDCF9Q35721251-2F9EFB36-C7C4-401D-BE24-085797284585Q36100154-879D0F61-7934-4D89-BD63-9DC305FF0E62Q36477630-4E5AF2DA-1AF7-41A0-8B4C-05D66A52920FQ37312231-BD251CE8-892C-4D82-9CA4-A46882646C44Q37526368-211B709E-A7AA-4C8E-A008-C33872945559Q37548393-D3B4CA1A-3703-467B-B681-4F2238AD172EQ37713257-8894ADF2-9319-4D36-9BB8-140455835229Q37723197-B0336AEB-B8FE-4823-8AB4-A766CC4BB6AEQ37978264-1C478B42-3E05-42B2-A1E5-8342F90E0E61Q38607979-F3230192-57FB-49A0-A111-2978FACEDC96Q39263101-B86965BF-5AF9-4C98-A589-D491126A699BQ40551968-4BC6A7A3-41C6-4B27-A1C5-D84C35D44DE5Q41811119-0CEED8DF-F8E7-4DB6-8926-FD9BAEE7CF1CQ43205982-F9081C38-59F1-4BC0-AC56-3E10A5E90CEBQ47562240-4512378C-503A-45DB-A2C0-144540B262D6Q48090121-477BC2DB-307D-44C9-BA91-5E677D244F23Q50117840-049BCBF6-68B0-495F-A49F-630CD809AB48Q50319836-60D5BBAF-B99A-41C8-8B6D-1F7CC69E0EC7Q55073455-37BCA31B-85F5-4983-8A7C-65E1D1A52645Q55241568-792675D2-64E3-4D2B-A132-C617CE6760BAQ55711941-E9F1A821-8A1B-4DEB-9550-7899ABE5D544Q57111430-CC9990B3-373F-425D-A58A-1AF93DB9D8C9Q57159543-282FC531-2E9D-4C2C-A50E-BE1B404CD2AA
P2860
Recent advances in the management of diabetic distal symmetrical polyneuropathy
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent advances in the management of diabetic distal symmetrical polyneuropathy
@en
type
label
Recent advances in the management of diabetic distal symmetrical polyneuropathy
@en
prefLabel
Recent advances in the management of diabetic distal symmetrical polyneuropathy
@en
P2860
P1476
Recent advances in the management of diabetic distal symmetrical polyneuropathy
@en
P2860
P356
10.1111/J.2040-1124.2010.00083.X
P577
2011-01-01T00:00:00Z